Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Chubb
Cantor Fitzgerald
Cipla
Colorcon
Express Scripts
Baxter
Citi

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078660

« Back to Dashboard

NDA 078660 describes ENOXAPARIN SODIUM, which is a drug marketed by Sandoz Inc, Amphastar Pharm, Sandoz, and Teva, and is included in four NDAs. Additional details are available on the ENOXAPARIN SODIUM profile page.

The generic ingredient in ENOXAPARIN SODIUM is enoxaparin sodium. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.
Summary for 078660
Tradename:ENOXAPARIN SODIUM
Applicant:Sandoz Inc
Ingredient:enoxaparin sodium
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 078660

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUS, SUBCUTANEOUSStrength300MG/3ML (100MG/ML)
Approval Date:Nov 28, 2011TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Merck
Farmers Insurance
Chubb
Baxter
AstraZeneca
Federal Trade Commission
Colorcon
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.